Elanco stock plummeted Thursday after the company announced a pair of delays and a surprise warning for its new eczema treatment for dogs.
Elanco Animal Health Incorporated (NYSE: ELAN) today announced updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
Passive investing in index funds can generate returns that roughly match the overall market. But if you pick the right...